We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+1.77%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$514M
AUM Growth
+$301M
Cap. Flow
+$293M
Cap. Flow %
57.02%
Top 10 Hldgs %
5.45%
Holding
1,025
New
585
Increased
167
Reduced
66
Closed
207

Top Buys

Rank Stock Value
1
SSRM icon
SSR Mining
SSRM
+$4.08M
2
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$3.92M
3
SMAR
Smartsheet Inc.
SMAR
+$2.98M
4
LEN icon
Lennar Class A
LEN
+$2.74M
5
DOW icon
Dow Inc
DOW
+$2.55M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$2.12M
2
HOLX
Hologic
HOLX
+$2.01M
3
MPC icon
Marathon Petroleum
MPC
+$1.66M
4
KO icon
Coca-Cola
KO
+$1.58M
5
JBL icon
Jabil
JBL
+$1.45M

Sector Composition

Rank Sector Weight
1 Technology 22.07%
2 Industrials 18.09%
3 Consumer Discretionary 13.93%
4 Healthcare 10.29%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BA icon
151
Boeing
BA
$185B
$1.01M 0.2%
+5,238
New +$1.08M
MAT icon
152
Mattel
MAT
$4.23B
$1.01M 0.2%
50,927
+9,836
+24% +$186K
INTU icon
153
Intuit
INTU
$89B
$1.01M 0.2%
+1,549
New +$989K
WH icon
154
Wyndham Hotels & Resorts
WH
$5.48B
$1.01M 0.2%
+13,113
New +$1.03M
MDU icon
155
MDU Resources
MDU
$4.32B
$994K 0.19%
71,177
+52,098
+273% +$603K
NKE icon
156
Nike
NKE
$61.9B
$991K 0.19%
+10,542
New +$1.07M
CIM
157
Chimera Investment
CIM
$1B
$985K 0.19%
+71,231
New +$992K
AIN icon
158
Albany International
AIN
$1.78B
$982K 0.19%
+10,499
New +$963K
MRVL icon
159
Marvell Technology
MRVL
$196B
$975K 0.19%
+13,755
New +$942K
WHR icon
160
Whirlpool
WHR
$2.82B
$973K 0.19%
+8,134
New +$907K
COST icon
161
Costco
COST
$420B
$969K 0.19%
1,323
-1,522
-53% -$1.09M
MUSA icon
162
Murphy USA
MUSA
$9.61B
$969K 0.19%
+2,311
New +$903K
TSLA icon
163
Tesla
TSLA
$1.3T
$967K 0.19%
+5,499
New +$1.07M
BEN icon
164
Franklin Resources
BEN
$17.2B
$964K 0.19%
34,283
+17,138
+100% +$472K
OKTA icon
165
Okta
OKTA
$25.8B
$958K 0.19%
+9,155
New +$844K
CHGG icon
166
Chegg
CHGG
$102M
$950K 0.19%
+125,518
New +$1.15M
MANH icon
167
Manhattan Associates
MANH
$11.4B
$937K 0.18%
3,746
-180
-5% -$42.9K
BIIB icon
168
Biogen
BIIB
$30.7B
$937K 0.18%
+4,346
New +$1.02M
ASH icon
169
Ashland
ASH
$3.5B
$936K 0.18%
+9,617
New +$861K
PNC icon
170
PNC Financial Services
PNC
$101B
$929K 0.18%
+5,749
New +$866K
GD icon
171
General Dynamics
GD
$106B
$924K 0.18%
+3,272
New +$875K
OC icon
172
Owens Corning
OC
$12.4B
$923K 0.18%
5,533
-6,567
-54% -$1M
INCY icon
173
Incyte
INCY
$24.4B
$919K 0.18%
16,136
+10,936
+210% +$656K
ROST icon
174
Ross Stores
ROST
$81.9B
$910K 0.18%
+6,198
New +$888K
STLD icon
175
Steel Dynamics
STLD
$37.6B
$906K 0.18%
6,114
+3,242
+113% +$408K
5 6
7
8 9

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Sherbrooke Park Advisers held 1,025 positions worth $514M, up 141% from $213M the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.

Sherbrooke Park Advisers deployed $293M of net new capital in Q1 2024, opening 585 new positions and adding to 167 existing holdings. Its largest new stake was Amylyx Pharmaceuticals: 299,452 shares worth $850K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Procter & Gamble, an estimated $2.12M trimmed.

  • Sherbrooke Park Advisers's largest Q1 2024 buy was Amylyx Pharmaceuticals: 299,452 shares worth $850K.
  • Sherbrooke Park Advisers added most to SSR Mining in Q1 2024, an estimated $4.08M increase.
  • Sherbrooke Park Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $2.12M.
  • Sherbrooke Park Advisers fully exited Hologic in Q1 2024, selling an estimated $2.01M.
  • Sherbrooke Park Advisers's ten largest holdings make up 5.5% of its $514M portfolio in Q1 2024.
  • Sherbrooke Park Advisers opened 585 new positions and closed 207 in Q1 2024.
  • Sherbrooke Park Advisers's portfolio value rose 141% quarter-over-quarter to $514M.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2024, filed 15 May 2024.